News & Analysis on Clinical Trial Services & Contract Research And Development
Santhera Pharmaceuticals and the Takeda Pharmaceutical Company have established a collaboration to develop and market the first treatment for Friedreich's Ataxia - a genetic condition that impacts quality of life substantially reducing patients' life...
Researchers have discovered a new tumour defence system that interferes with the cells that are trying to kill them. These results raise the possibility of new drug targets for cancer such as those that may transport free fatty acids out of the tumour.
German specialty chemicals group, H&R Wasag, increased its sales and earnings in the first half of the year, helped by its in-house refinery operations that allow it to anticipate and react early to changing oil prices.
Expression Analysis introduces a new technique that is set to improve the performance of the Affymetrix Genechip. The technique, which eliminates the effect caused by potentially invariant probes within a probe set, will provide cost and time savings...
Sun Pharmaceutical Industries has become the second Indian drugmaker in a matter of days to announce the purchase of a manufacturing facility in Eastern Europe that will serve as a springboard for expansion into the broader European marketplace.
Diosynth Biotechnology, the contract manufacturing subsidiary of Dutch chemicals and pharmaceuticals group Akzo Nobel, has won a new contract to manufacture a cardiovascular imaging agent due to start Phase III testing in 2006.